Cepton, Inc. Reports Second Quarter 2024 Results

Actual results, performance or achievements may, and are likely to, differ materially, and potentially adversely, from any projections and forward-looking statements and the assumptions on which those forward-looking statements were based. There can be no assurance that the data contained herein is reflective of future performance to any degree. You are cautioned not to place undue reliance on forward-looking statements as a predictor of future performance as projected financial information and other information are based on estimates and assumptions that are inherently subject to various significant risks, uncertainties and other factors, many of which are beyond Cepton’s control.

Non-GAAP Financial Measures

Some of the financial information and data contained in this press release, such as Non-GAAP net income (loss) and adjusted EBITDA, have not been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”). Non-GAAP net income (loss) is defined as GAAP net income (loss) excluding stock-based compensation, realizable gain from series production award cancellation loss recovery, non-recurring transaction expenses, gain on sales of property and equipment, gain or loss on changes in fair value of earnout liability and warrants, foreign currency transaction loss, net, and loss on extinguishment of debt. As a result of the cancellation of the GM series production award in December 2023, Cepton submitted a project investment cost recovery claim and realized a gain from project cancellation cost recovery in the six months ended June 30, 2024. This gain is excluded from the calculation of Non-GAAP net income (loss). Adjusted EBITDA is defined as Non-GAAP net income (loss) before interest income or expense, provision for income taxes, and depreciation and amortization.

Cepton believes these non-GAAP financial measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Cepton’s financial condition and results of operations. Cepton believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating actual and projected operating results and trends in comparing Cepton’s financial measures with other similar companies, many of which present similar non-GAAP financial measures to investors. Cepton also believes that adjusted EBITDA is useful to investors and analysts in assessing our operating performance during the periods these charges were incurred on a consistent basis with the periods during which these charges were not incurred. Our presentation of adjusted EBITDA should not be considered as an inference that our future results and financial position will be unaffected by unusual items. Cepton does not consider these non-GAAP financial measures in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and other amounts that are required by GAAP to be recorded in Cepton’s financial statements. In addition, they are subject to inherent limitations as they reflect the exercise of judgments by management about which expenses and other amounts are excluded or included in determining these non-GAAP financial measures.

CEPTON, INC. AND SUBSIDIARIES

Reconciliation of GAAP Net Income (Loss) to Non-GAAP Net Income (Loss) and Non-GAAP Adjusted EBITDA

(In thousands, except share and per share data)

(unaudited)

 

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

 

2024

 

2023 (1)

 

2024

 

2023 (1)

Net income (loss)

$

181

 

 

$

(14,190

)

 

$

(6,652

)

 

$

(28,932

)

Stock-based compensation

 

1,498

 

 

 

3,307

 

 

 

2,424

 

 

 

4,654

 

Gain from project cancellation cost recovery

 

 

 

 

 

 

 

(4,000

)

 

 

 

Non-recurring transaction expenses

 

62

 

 

 

 

 

 

1,622

 

 

 

2,709

 

Gain on sales of property and equipment

 

(60

)

 

 

 

 

 

(60

)

 

 

 

Gain (loss) on change in fair value of earnout liability

 

(59

)

 

 

26

 

 

 

(59

)

 

 

(736

)

Loss (gain) on change in fair value of warrant liability

 

11

 

 

 

(36

)

 

 

18

 

 

 

(130

)

Foreign currency transaction loss, net

 

 

 

 

 

 

 

 

 

 

750

 

Loss on extinguishment of debt

 

 

 

 

 

 

 

 

 

 

1,123

 

Non-GAAP net income (loss)

$

1,633

 

 

$

(10,893

)

 

$

(6,707

)

 

$

(20,562

)

Interest income, net

 

(613

)

 

 

(917

)

 

 

(1,267

)

 

 

(1,216

)

(Benefit) provision for income taxes

 

(21

)

 

 

3

 

 

 

(14

)

 

 

3

 

Depreciation and amortization

 

101

 

 

 

167

 

 

 

204

 

 

 

235

 

Adjusted EBITDA

$

1,100

 

 

$

(11,640

)

 

$

(7,784

)

 

$

(21,540

)

 

 

 

 

 

 

 

 

Net income (loss)

$

181

 

 

$

(14,190

)

 

$

(6,652

)

 

$

(28,932

)

Less: cumulative preferred stock dividends

 

(1,118

)

 

 

(1,071

)

 

 

(2,224

)

 

 

(1,909

)

Net loss attributable to common stockholders

$

(937

)

 

$

(15,261

)

 

$

(8,876

)

 

$

(30,841

)

 

 

 

 

 

 

 

 

Non-GAAP net income (loss)

$

1,633

 

 

$

(10,893

)

 

$

(6,707

)

 

$

(20,562

)

Less: cumulative preferred stock dividends

 

(1,118

)

 

 

(1,071

)

 

 

(2,224

)

 

 

(1,909

)

Non-GAAP net income (loss) attributable to common stockholders

$

515

 

 

$

(11,964

)

 

$

(8,931

)

 

$

(22,471

)

 

 

 

 

 

 

 

 

GAAP net loss per share attributable to common stockholders:

 

 

 

 

 

 

 

Basic

$

(0.06

)

 

$

(0.97

)

 

$

(0.56

)

 

$

(1.96

)

Diluted

$

(0.06

)

 

$

(0.97

)

 

$

(0.56

)

 

$

(1.96

)

Non-GAAP net income (loss) per share attributable to common stockholders:

 

 

 

 

 

 

 

Basic

$

0.03

 

 

$

(0.76

)

 

$

(0.56

)

 

$

(1.43

)

Diluted

$

0.03

 

 

$

(0.76

)

 

$

(0.56

)

 

$

(1.43

)

Shares used in computing GAAP net loss per share attributable to common stockholders:

 

 

 

 

 

 

 

Basic

 

15,978,032

 

 

 

15,737,917

 

 

 

15,933,150

 

 

 

15,708,102

 

Diluted

 

15,978,032

 

 

 

15,737,917

 

 

 

15,933,150

 

 

 

15,708,102

 

Shares used in computing Non-GAAP net income (loss) per share attributable to common stockholders:

 

 

 

 

 

 

 

Basic

 

15,978,032

 

 

 

15,737,917

 

 

 

15,933,150

 

 

 

15,708,102

 

Diluted

 

16,238,148

 

 

 

15,737,917

 

 

 

15,933,150

 

 

 

15,708,102

 

(1)

Prior period figures are presented as adjusted for the one-for-ten reverse stock split of Cepton’s issued common stock (the “Reverse Stock Split”) effective on September 21, 2023.

CEPTON, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(In thousands, except share data)

(unaudited)

 

 

June 30,
2024

 

December 31,
2023

ASSETS

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

56,021

 

 

$

50,406

 

Short-term investments

 

 

 

 

5,969

 

Accounts receivable, net of allowance for credit losses of $0 and $0

 

333

 

 

 

3,625

 

Inventories

 

1,235

 

 

 

2,396

 

Prepaid expenses and other current assets

 

3,393

 

 

 

1,253

 

Total current assets

 

60,982

 

 

 

63,649

 

Property and equipment, net

 

1,249

 

 

 

1,450

 

Restricted cash

 

1,283

 

 

 

1,283

 

Other assets

 

9,167

 

 

 

10,067

 

Total assets

$

72,681

 

 

$

76,449

 

LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

2,877

 

 

$

1,128

 

Operating lease liabilities, current

 

2,045

 

 

 

1,875

 

Accrued expenses and other current liabilities

 

3,833

 

 

 

4,066

 

Total current liabilities

 

8,755

 

 

 

7,069

 

Warrant liability

 

61

 

 

 

43

 

Earnout liability

 

34

 

 

 

93

 

Operating lease liabilities, non-current

 

7,635

 

 

 

8,720

 

Total liabilities

 

16,485

 

 

 

15,925

 

Commitments and contingencies (Note 17)

 

 

 

Convertible preferred stock with a related party:

 

 

 

Convertible preferred stock – Par value $0.00001 per share – 5,000,000 shares authorized; 100,000 shares issued and outstanding (aggregate liquidation preference of $106.3 million and $104.1 million)

 

98,891

 

 

 

98,891

 

Stockholders’ equity (deficit):

 

 

 

Common stock – Par value $0.00001 per share – 35,000,000 shares authorized; 16,043,207 and 15,861,494 shares issued and outstanding

 

 

 

 

 

Additional paid-in capital

 

98,913

 

 

 

96,583

 

Accumulated other comprehensive loss

 

(351

)

 

 

(345

)

Accumulated deficit

 

(141,257

)

 

 

(134,605

)

Total stockholders’ equity (deficit)

 

(42,695

)

 

 

(38,367

)

Total liabilities, convertible preferred stock and stockholders’ equity (deficit)

$

72,681

 

 

$

76,449

 

CEPTON, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

(In thousands, except share and per share data)

(unaudited)

 

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

 

2024

 

2023 (1)

 

2024

 

2023 (1)

Lidar sensor and prototype revenue

$

374

 

 

$

2,771

 

 

$

1,515

 

 

$

4,011

 

Development revenue

 

10,054

 

 

 

16

 

 

 

10,859

 

 

 

261

 

Total revenue

 

10,428

 

 

 

2,787

 

 

 

12,374

 

 

 

4,272

 

 

 

 

 

 

 

 

 

Lidar sensor and prototype cost of revenue

 

976

 

 

 

2,348

 

 

 

2,188

 

 

 

3,796

 

Development cost of revenue

 

3,098

 

 

 

5

 

 

 

3,409

 

 

 

116

 

Total cost of revenue

 

4,074

 

 

 

2,353

 

 

 

5,597

 

 

 

3,912

 

Gross profit

 

6,354

 

 

 

434

 

 

 

6,777

 

 

 

360

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

Research and development

 

3,234

 

 

 

9,365

 

 

 

8,888

 

 

 

16,603

 

Selling, general and administrative

 

3,709

 

 

 

6,185

 

 

 

9,973

 

 

 

12,916

 

Total operating expenses

 

6,943

 

 

 

15,550

 

 

 

18,861

 

 

 

29,519

 

Operating loss

 

(589

)

 

 

(15,116

)

 

 

(12,084

)

 

 

(29,159

)

Other income (expense):

 

 

 

 

 

 

 

Gain (loss) on change in fair value of earnout liability

 

59

 

 

 

(26

)

 

 

59

 

 

 

736

 

(Loss) gain on change in fair value of warrant liability

 

(11

)

 

 

36

 

 

 

(18

)

 

 

130

 

Other income, net

 

88

 

 

 

2

 

 

 

4,110

 

 

 

21

 

Loss on extinguishment of debt

 

 

 

 

 

 

 

 

 

 

(1,123

)

Foreign currency transaction loss, net

 

 

 

 

 

 

 

 

 

 

(750

)

Interest income, net

 

613

 

 

 

917

 

 

 

1,267

 

 

 

1,216

 

Income (loss) before income taxes

 

160

 

 

 

(14,187

)

 

 

(6,666

)

 

 

(28,929

)

Benefit (provision) for income taxes

 

21

 

 

 

(3

)

 

 

14

 

 

 

(3

)

 

 

 

 

 

 

 

 

Net income (loss)

$

181

 

 

$

(14,190

)

 

$

(6,652

)

 

$

(28,932

)

Less: cumulative preferred stock dividends

 

(1,118

)

 

 

(1,071

)

 

 

(2,224

)

 

 

(1,909

)

Net loss attributable to common stockholders

$

(937

)

 

$

(15,261

)

 

$

(8,876

)

 

$

(30,841

)

 

 

 

 

 

 

 

 

Net loss per share attributable to common stockholders, basic

$

(0.06

)

 

$

(0.97

)

 

$

(0.56

)

 

$

(1.96

)

Net loss per share attributable to common stockholders, diluted

$

(0.06

)

 

$

(0.97

)

 

$

(0.56

)

 

$

(1.96

)

Weighted-average common shares, basic

 

15,978,032

 

 

 

15,737,917

 

 

 

15,933,150

 

 

 

15,708,102

 

Weighted-average common shares, diluted

 

15,978,032

 

 

 

15,737,917

 

 

 

15,933,150

 

 

 

15,708,102

 

(1)

Prior period figures are presented as adjusted for the Reverse Stock Split effective on September 21, 2023.

CEPTON, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(In thousands)

(unaudited)

 

 

Six Months Ended
June 30,

 

2024

 

2023

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

Net loss

$

(6,652

)

 

$

(28,932

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

Depreciation and amortization

 

204

 

 

 

235

 

Stock-based compensation

 

2,424

 

 

 

4,654

 

Amortization of right-of-use asset

 

826

 

 

 

773

 

Gain on sales of property and equipment

 

(60

)

 

 

 

Accretion, other

 

(25

)

 

 

(373

)

Gain on change in fair value of earnout liability

 

(59

)

 

 

(736

)

Loss (gain) on change in fair value of warrant liability

 

18

 

 

 

(130

)

Foreign currency transaction loss, net

 

 

 

 

750

 

Loss from extinguishment of debt

 

 

 

 

1,123

 

Changes in operating assets and liabilities:

 

 

 

Accounts receivable, net

 

3,292

 

 

 

(791

)

Inventories

 

1,161

 

 

 

(1,216

)

Prepaid expenses and other current assets

 

(2,140

)

 

 

1,958

 

Other long-term assets

 

74

 

 

 

202

 

Accounts payable

 

1,749

 

 

 

741

 

Accrued expenses and other current liabilities

 

(232

)

 

 

791

 

Operating lease liabilities

 

(915

)

 

 

(289

)

Net cash used in operating activities

 

(335

)

 

 

(21,240

)

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

Purchases of property and equipment

 

(3

)

 

 

(1,186

)

Purchases of short-term investments

 

 

 

 

(37,806

)

Proceeds from sales of property and equipment

 

60

 

 

 

 

Proceeds from maturities of short-term investments

 

6,000

 

 

 

5,200

 

Net cash provided by (used in) investing activities

 

6,057

 

 

 

(33,792

)

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

Proceeds from convertible preferred stock with a related party, net of transaction costs

 

 

 

 

99,884

 

Repayment of secured term loan from a related party

 

 

 

 

(45,220

)

Proceeds from issuance of common stock options

 

4

 

 

 

13

 

Payments of employee taxes related to vested restricted stock units

 

(98

)

 

 

(63

)

Net cash (used in) provided by financing activities

 

(94

)

 

 

54,614

 

 

 

 

 

Effect of exchange rate changes on cash

 

(13

)

 

 

429

 

 

 

 

 

Net increase in cash, cash equivalents and restricted cash

 

5,615

 

 

 

11

 

Cash, cash equivalents and restricted cash, beginning of period

 

51,689

 

 

 

34,518

 

Cash, cash equivalents and restricted cash, end of period

$

57,304

 

 

$

34,529

 





© 2024 Internet Business Systems, Inc.
670 Aberdeen Way, Milpitas, CA 95035
+1 (408) 882-6554 — Contact Us
ShareCG™ is a trademark of Internet Business Systems, Inc.

Report a Bug Report Abuse Make a Suggestion About Privacy Policy Contact Us User Agreement Advertise